Kelly CRISPR & Gene Editing Technology
$42.86
5
+$0.76+1.8%Wednesday 19:22
Statistics
Day High
42.86
Day Low
42.86
52W High
44.05
52W Low
5.87
Volume
200
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Expense Ratio
0.78%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.
Dividends
0%Dividend Yield
Dec 2023
$7.38
Dec 2022
$0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Holdings
Regions
Sectors
About
The adviser employs a "passive management" investment approach designed to track the total return performance of the index. The index is a rules-based index that consists of the stocks or corresponding depositary receipts of companies engaged in the creation, development, production, operation, provision, distribution, ownership, servicing, licensing, leasing or franchising of at least one of the DNA Modification Technology Business. The fund invests at least 80% of its net assets in DNA Modification Technology Companies. It is non-diversified.
Show More
CEO
Country
United States
ISIN
US48817R7061
Listings
0 Comments
Share your thoughts
FAQs
What is Kelly CRISPR & Gene Editing Technology stock price today?▼
The current price of XDNA is $42.86 USD — it has increased by +1.8% in the past 24 hours. Watch Kelly CRISPR & Gene Editing Technology stock price performance more closely on the chart.
What is Kelly CRISPR & Gene Editing Technology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Kelly CRISPR & Gene Editing Technology stocks are traded under the ticker XDNA.
Does Kelly CRISPR & Gene Editing Technology pay dividends?▼
Yes, XDNA dividends are paid annual. The last dividend per share was 7.38 . As of today, Dividend Yield (FWD)% is 0%.
In which sector is Kelly CRISPR & Gene Editing Technology located?▼
Kelly CRISPR & Gene Editing Technology operates in the Other sector.
When did Kelly CRISPR & Gene Editing Technology complete a stock split?▼
Kelly CRISPR & Gene Editing Technology has not had any recent stock splits.